Article
Combinatorial biosynthesis of lipopeptide antibiotics in Streptomyces roseosporus
28 Sept 2005
Abstract excerpt
Daptomycin is a cyclic lipopeptide antibiotic produced by Streptomyces roseosporus. Cubicin (daptomycin-for-injection) was approved in 2003 by the FDA to treat skin and skin structure infections caused by Gram-positive pathogens. Daptomycin is particularly significant in that it represents the first new natural product antibacterial structural class approved for clinical use in three decades. The daptomycin gene...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
